Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Fibrin-specific breakdown and activation of the endogenous fibrinolytic system

Fibrinolysis & Antithrombotic Enzymatic Activity · Vascular endothelium and hemodynamics

Directly breaks down cross-linked fibrin networks and stimulates vascular endothelium to release tissue-type plasminogen activator (t-PA), reducing platelet aggregation and blood viscosity.

Why it matters: Prevents venous thrombosis, improves deep varicose veins and microvascular resistance in the heart and brain, and keeps microcirculatory blood flow open.

Molecular targets: Fibrin, t-PA, PAI-1 inhibition, Reduced red blood cell aggregation

Supplements acting on this mechanism (ranked by strength and evidence)

Lumbrokinase

★★★★☆Mechanism evidence: grade A

Lumbrokinase can act on fibrin. A human randomized study observed higher t-PA activity and D-dimer and lower fibrinogen, so fibrinolysis-related human markers did change. However, fibrin breakdown in vitro does not show that the intact enzyme directly breaks up microthrombi in humans, and the contribution of direct enzymatic cleavage is not established.

Nattokinase

★★★☆☆Mechanism evidence: grade A

Nattokinase has direct fibrinolytic activity in vitro. A single 2000 FU dose can briefly raise fibrin degradation markers in humans, but it is unclear whether the active enzyme reaches the blood reliably. Direct cleavage of fibrin or inactivation of PAI-1 has also not been confirmed in humans.

Open in the interactive app ›